These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 18665910
1. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis. Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M. Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910 [Abstract] [Full Text] [Related]
2. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects. Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C. Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901 [Abstract] [Full Text] [Related]
3. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE. Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348 [Abstract] [Full Text] [Related]
4. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S. Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237 [Abstract] [Full Text] [Related]
5. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. Ahmed A, Rabbitt E, Brady T, Brown C, Guest P, Bujalska IJ, Doig C, Newsome PN, Hubscher S, Elias E, Adams DH, Tomlinson JW, Stewart PM. PLoS One; 2012 Oct; 7(2):e29531. PubMed ID: 22363403 [Abstract] [Full Text] [Related]
8. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH. Abrahams L, Semjonous NM, Guest P, Zielinska A, Hughes B, Lavery GG, Stewart PM. J Endocrinol; 2012 Sep; 214(3):367-72. PubMed ID: 22718432 [Abstract] [Full Text] [Related]
9. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM. Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176 [Abstract] [Full Text] [Related]
10. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Li X, Lindquist S, Chen R, Myrnäs T, Angsten G, Olsson T, Hernell O. Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929 [Abstract] [Full Text] [Related]
15. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, Grino M. Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188 [Abstract] [Full Text] [Related]
17. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB. Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559 [Abstract] [Full Text] [Related]
18. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ. Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533 [Abstract] [Full Text] [Related]